Abiopharma

New Form 8-K - ADC Therapeutics SA Filed: 2025-06-12 AccNo: 0000950103-25-007282 Size: 473 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.05: Cost Associated with Exit or Disposal Activities Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits